The 2026 ADA Standards of Care, released at the meeting, formally elevated cardiovascular and kidney risk reduction to a co-primary treatment goal alongside blood sugar control ending decades of practice in which A1C was the dominant benchmark
However, as we mentioned in the introduction, we still need more research to confirm these benefits
Clinical trials show patients lose weight while actually eating, not starving, which explains why many describe the experience as effortless compared to previous diet attempts
iScience 26(1):105850 Hanahan D (2022) Hallmarks of cancer: new dimensions
Talk with your own clinician before starting a GLP-1, especially if you are managing menopause symptoms, thyroid conditions, or anything else